CLINICAL-EXPERIENCE WITH TILAVIST - AN OVERVIEW OF EFFICACY AND SAFETY

被引:34
作者
KJELLMAN, NIM [1 ]
STEVENS, MT [1 ]
机构
[1] FISONS PLC,DIV PHARMACEUT,RES & DEV LABS,LOUGHBOROUGH LE11 0RH,LEICS,ENGLAND
关键词
D O I
10.1111/j.1398-9995.1995.tb04252.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
A programme of clinical studies was carried out to determine the basic efficacy and safety of 2% nedocromil sodium eye drops (Tilavist) in treating allergic conjunctivitis, in 2,905 patients from 3-76 years of age. Results of all the double-masked placebo comparative studies completed to date - five in vernal keratoconjunctivitis (VKC), five in perennial (PAC) and 16 in seasonal allergic conjunctivitis (SAC) - have been assessed in a statistical overview analysis. Nedocromil sodium, administered four times daily to 153 patients with VKC, was significantly more effective than placebo (155 patients) and in the clinicians' opinion gave good control in 76% of cases, compared with 46% for placebo (p < 0.001). Patients with chronic symptoms of PAC also responded better to nedocromil sodium given four times daily (n = 146) rather than twice daily (n = 86), and significantly more patients (p < 0.001) were effectively controlled by four times daily treatment with nedocromil sodium (72%) than with placebo (47%; n = 156). Twice-daily dosage with nedocromil sodium (n = 677) was adequate for SAC, however, and the treatment was statistically better than placebo (p < 0.01-p < 0.001) whether dosed twice or four times daily. Speed of action was assessed in seven SAC studies in which 79% of all patients (n = 295) using nedocromil sodium had experienced relief of symptoms when questioned, half of them within 15 minutes and 74% during the first hour after dosing. Test treatments were well-accepted by both adults and children, and there were no major adverse events. Minor irritations reported more frequently with nedocromil sodium than placebo were stinging or burning of the eyes on application of the drops and a distinctive taste, noted by 5% of the active treatment group (n = 1,552).
引用
收藏
页码:14 / 22
页数:9
相关论文
共 12 条
[1]  
ADENIS JP, 1994, ALLERGY CLIN IMMUN S, V2, P15
[2]   EFFECTIVENESS OF NEDOCROMIL SODIUM 2-PERCENT EYEDROPS ON CLINICAL SYMPTOMS AND TEAR FLUID CYTOLOGY OF PATIENTS WITH VERNAL CONJUNCTIVITIS [J].
BONINI, S ;
BARNEY, NP ;
SCHIAVONE, M ;
CENTOFANTI, M ;
BERRUTO, A ;
BONINI, S ;
ALLANSMITH, MR .
EYE, 1992, 6 :648-652
[3]   ANTIINFLAMMATORY EFFECTS OF NEDOCROMIL SODIUM - INHIBITION OF ALVEOLAR MACROPHAGE FUNCTION [J].
BORISH, L ;
WILLIAMS, J ;
JOHNSON, S ;
MASCALI, JJ ;
MILLER, R ;
ROSENWASSER, LJ .
CLINICAL AND EXPERIMENTAL ALLERGY, 1992, 22 (11) :984-990
[4]   THE DEVELOPMENT OF A NEW AGENT FOR THE TREATMENT OF INFLAMMATORY ALLERGIC CONDITIONS [J].
CAIRNS, H ;
ORR, TSC .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1987, 82 (3-4) :513-517
[5]   LEVOCABASTINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL AS A TOPICAL ANTIHISTAMINE IN ALLERGIC RHINITIS AND CONJUNCTIVITIS [J].
DECHANT, KL ;
GOA, KL .
DRUGS, 1991, 41 (02) :202-224
[6]   A DOUBLE-BLIND PLACEBO-CONTROLLED GROUP COMPARATIVE-STUDY OF OPHTHALMIC SODIUM CROMOGLYCATE AND NEDOCROMIL SODIUM IN THE TREATMENT OF VERNAL KERATOCONJUNCTIVITIS [J].
ELHENNAWI, M .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1994, 78 (05) :365-369
[7]  
Knottnerus I G, 1993, Ocul Immunol Inflamm, V1, P27, DOI 10.3109/09273949309086533
[8]   EFFECTS OF SODIUM CROMOGLYCATE AND NEDOCROMIL SODIUM ON HISTAMINE-SECRETION FROM HUMAN-LUNG MAST-CELLS [J].
LEUNG, KBP ;
FLINT, KC ;
BROSTOFF, J ;
HUDSPITH, BN ;
JOHNSON, NM ;
LAU, HYA ;
LIU, WL ;
PEARCE, FL .
THORAX, 1988, 43 (10) :756-761
[9]   NEDOCROMIL SODIUM 2-PERCENT EYE DROPS FOR TWICE-DAILY TREATMENT OF SEASONAL ALLERGIC CONJUNCTIVITIS - A SWEDISH MULTICENTER PLACEBO-CONTROLLED STUDY IN CHILDREN ALLERGIC TO BIRCH POLLEN [J].
MOLLER, C ;
BERG, IM ;
BERG, T ;
KJELLMAN, M ;
STROMBERG, L .
CLINICAL AND EXPERIMENTAL ALLERGY, 1994, 24 (09) :884-887
[10]   ALBUTEROL AND NEDOCROMIL SODIUM AFFECT AIRWAY AND LEUKOCYTE RESPONSES TO ALLERGEN [J].
TWENTYMAN, OP ;
SAMS, VR ;
HOLGATE, ST .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (06) :1425-1430